
Über diesen Podcast
A podcast about pharmacy and oncology
18 Folgen · health
PharmOncology
Neueste FolgeDoes levetiracetam makes sense for ICANS?
Über diesen Podcast
A podcast about pharmacy and oncology
Neue Folgen
- Is zanidatamab better than trastuzumab in HER2 IHC 2+?2. Sept. · 12 Min.
- ESR1 mutations, elacestrant, imlunestrant, and vepdegestrant26. Aug. · 11 Min.
- Explaining CELMoDs in 10 minutes19. Aug. · 9 Min.
- Does chemo work in extensive stage small cell lung cancer?12. Aug. · 9 Min.
- Why current HER2 testing is flawed5. Aug. · 12 Min.
- Chemotherapy (and especially platinum) Resistance29. Juli · 12 Min.
- VIKTORIA-1: Appropriate control arm?22. Juli · 12 Min.
- What's the difference between the DLBCL second-line regimens?15. Juli · 16 Min.
- Why don't we have a pan-tumor drug that targets BRCA mutations?8. Juli · 8 Min.
- DESTINY-Breast11 and Surrogate Endpoints1. Juli · 7 Min.